Editor’s note: This story was updated on January 31 with comment from Pfizer.
A rare peek into drug company documents reveals troubling differences between publicly available information and materials the company holds close to its chest.
Log in
Subscribers, enter your e-mail address for full access to the Science News archives and digital editions.